McKesson Corporation  

(Public, NYSE:MCK)   Watch this stock  
Find more results for MCK
-0.54 (-0.26%)
Real-time:   11:20AM EST
NYSE real-time data - Disclaimer
Currency in USD
Range 210.39 - 213.19
52 week 158.31 - 214.37
Open 211.47
Vol / Avg. 163,148.00/929,178.00
Mkt cap 48.83B
P/E 34.68
Div/yield 0.24/0.46
EPS 6.07
Shares 232.00M
Beta 0.72
Inst. own 86%
Jan 28, 2015
Q3 2015 McKesson Corp Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Jan 13, 2015
McKesson Corp at JPMorgan Healthcare Conference - 1:00PM EST - Add to calendar
Nov 11, 2014
McKesson Corp at Credit Suisse Healthcare Conference
Oct 28, 2014
Q2 2015 McKesson Corp Earnings Call
Oct 28, 2014
Q2 2015 McKesson Corp Earnings Release
Sep 30, 2014
McKesson Corp at Leerink Partners Services Roundtable
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2014
Net profit margin 1.10% 0.98%
Operating margin 1.76% 1.72%
EBITD margin - 2.46%
Return on average assets 3.74% 3.13%
Return on average equity 21.63% 17.43%
Employees 42,800 -
CDP Score - -


United States - Map
+1-415-9838300 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia


McKesson Corporation delivers pharmaceuticals, medical supplies and healthcare information technologies. The Company operates in two segments: McKesson Distribution Solutions segment and McKesson Technology Solutions segment. The McKesson Distribution Solutions segment distributes drugs, medical-surgical supplies and equipment and health and beauty care products throughout North America. The McKesson Technology Solutions segment delivers enterprise clinical, patient care, financial, supply chain, strategic management software solutions, pharmacy automation for hospitals, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations. In February 2013, the Company completed acquisition of Pss World Medical Inc. In February 2014, McKesson Corporation announced that its ownership in Celesio AG exceeds 75% interest.

Officers and directors

John Harvey Hammergren Chairman of the Board, President, Chief Executive Officer
Age: 55
Bio & Compensation  - Reuters
James A. Beer Chief Financial Officer, Executive Vice President
Age: 53
Bio & Compensation  - Reuters
Randall N. Spratt Chief Information Officer, Chief Technology Officer, Executive Vice President
Age: 62
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Lori A. Schechter Executive Vice President, Chief Compliance Officer, General Counsel
Bio & Compensation  - Reuters
Jorge L. Figueredo Executive Vice President - Human Resources
Age: 53
Bio & Compensation  - Reuters
Patrick J. Blake Executive Vice President, Group President
Age: 50
Bio & Compensation  - Reuters
Paul Coleman Julian Executive Vice President, Group President
Age: 59
Bio & Compensation  - Reuters
Brian S. Tyler Ph.D. Executive Vice President - Corporate Strategy and Business Development
Age: 47
Bio & Compensation  - Reuters
Andrew D. Bryant Independent Director
Age: 64
Bio & Compensation  - Reuters
Wayne A. Budd Independent Director
Age: 72
Bio & Compensation  - Reuters